VanEck Associates’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-37,118
Closed -$1.03M 1400
2024
Q2
$1.03M Buy
37,118
+863
+2% +$25.7K ﹤0.01% 993
2024
Q1
$1.22M Buy
36,255
+3,940
+12% +$128K ﹤0.01% 955
2023
Q4
$1.09M Sell
32,315
-1,976
-6% -$60.7K ﹤0.01% 948
2023
Q3
$1.11M Buy
34,291
+24,328
+244% +$820K ﹤0.01% 877
2023
Q2
$324K Buy
9,963
+1,576
+19% +$47.5K ﹤0.01% 1110
2023
Q1
$266K Sell
8,387
-529
-6% -$15.9K ﹤0.01% 1124
2022
Q4
$268K Buy
8,916
+2,519
+39% +$78.2K ﹤0.01% 1033
2022
Q3
$201K Buy
+6,397
New +$205K ﹤0.01% 1026

Other funds holding OPCH

VanEck Associates's OPCH Position: Q3 2024 in Review

VanEck Associates sold out of Option Care Health (OPCH) in Q3 2024, closing a stake of 37,118 shares — an estimated $1.03M sold.

VanEck Associates first reported a position in OPCH in Q3 2022 and held it in 8 quarters. The position peaked at $1.22M in Q1 2024. 339 funds tracked by Wall St. Rank hold OPCH as of Q3 2024.

  • VanEck Associates reported no remaining Option Care Health position as of Q3 2024 after selling out during the quarter.
  • VanEck Associates sold 37,118 Option Care Health shares in Q3 2024, an estimated $1.03M.
  • VanEck Associates first reported a position in Option Care Health in Q3 2022 and held it in 8 quarters.
  • VanEck Associates's Option Care Health position peaked at $1.22M in Q1 2024.
  • 339 funds tracked by Wall St. Rank held Option Care Health as of Q3 2024.

Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.